Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,431
Sort by:
US Oncologist Survey: Optimizing Treatment for Advanced Lung Cancer
US$ 1,200.00
... to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment ... with adenocarcinoma Former light smoker whose cancer is EGFR positive Treatment decisions for advanced stages of cancer are difficult to track as information ...
April 2011
56 pages
The Blood Banking Market
US$ 22,880.00
... Global PDF: US$ 62,900.00 About This Report The “Blood Banking Market” report is part of a multiclient study series published by VENTURE PLANNING GROUP ... segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. Test volume and sales ...
April 2011
850 pages
Japan Diabetes Market Report & Forecast 2011-2016
US$ 750.00
IMARC’s new report “Japan Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future tre...
April 2011
37 pages
Competitor Analysis: Targeted Therapy of Diabetes
US$ 1,735.00
Product description The present Competitive Intelligence Report about Targeted Therapy of Diabetes provides a competitor evaluation in the field of novel molecules being developed for treatment of type 1 and 2 diabetes as of April 2011. Major pharmacologic approaches include insulin, PPAR agonists, DPP-IV ...
April 2011
114 pages
Castration Resistant Prostate Cancer: Clinical Insights from a US Oncologists' Survey
US$ 500.00
... for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment and testing choices, factors ... are missing, directly from high-prescribing US oncologists on the treatment of patients with advanced prostate cancer. Treatment decisions for advanced stages ...
March 2011
24 pages
US Oncologist Survey: Optimizing Treatment for Advanced Prostate Cancer
US$ 1,200.00
... that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open ... , barriers to optimal care, and confidence in treatment. Patients include: Patient case scenarios that progressively unfold, presented to 154 oncologists in a survey for ...
March 2011
52 pages
Diabetes Market in UAE
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,200.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00 Diabetes is the world’s most costly epidemic. It is anticipated that, over...
February 2011
35 pages
Competitor Analysis: Cancer Antibodies in Early Clinical Development
US$ 1,210.00
... CD20, VEGF and Her2, but also of many new and unique antibodies directed against novel targets which will have to show its ... cancer. In addition, the report lists company-specific R&D pipelines of anti-cancer antibodies. Competitor projects are listed in a tabular format providing information on: Drug Codes, ...
February 2011
183 pages
Oncologist Survey: Optimizing Treatment for Advanced Renal Cell Cancer
US$ 500.00
Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is actually happening ...
February 2011
59 pages
US Oncologist Survey: Optimizing Treatment for Metastatic Breast Cancer
US$ 1,200.00
Treatment decisions for advanced stages of breast cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is actually happening at ...
January 2011
59 pages
Triple Positive Metastatic Breast Cancer: Clinical Insights from a US Oncologists Survey
US$ 500.00
... the report, presented to 174 high-prescribing oncologists on Triple Positive Metastatic Breast Cancer for their open responses on clinical decisions. Patient ... the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open responses on clinical decisions. ...
January 2011
30 pages
Incontinence - Finland
US$ 900.00
Incontinence products grew by 2% in current value sales terms in 2009. The increasing demand for private label brands as a result of the economic downturn held back current values growth. However, con...
December 2010
31 pages
U.S. Market for Bone Marrow Aspiration and Concentration Devices
US$ 3,995.00
... & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring Main Segments Included: Bone Marrow Concentration Market Bone Marrow Aspirate Concentration Market Companies Included: Arteriocyte Medical Systems Harvest Technologies Biomet Exactech Reasons To Buy: This report ...
October 2010
50 pages
The World Market for Diabetes Treatments
US$ 2,995.00
Price (Single User PDF): $2,995.00 Price (Global Site License): $5,990.00 This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the...
October 2010
260 pages
Global Diagnostic ECG Market (2010 - 2015)
US$ 5,650.00
... levels in these regions are also expected to boost market growth. Thus, the global DECG market is expected to register high single digit growth despite ... categorizes the global market for diagnostic ECG devices by equipment type into following segments: Rest Systems Stress Systems Holter Monitors The DECG market is analyzed ...
October 2010
122 pages
Bladder Cancer Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, ... many key and niche players such as Affitech A/S, Allergan, Inc., Allos Therapeutics, Inc., Astellas Pharma, Inc., Astrazeneca Plc, AVI BioPharma, Inc., ...
October 2010
580 pages
Alzheimer Disease Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Alzheimer Disease Therapy Area Pipeline Report contains detailed information on the alzheimer disease drug pipeline. This report provides insight into the pipeline status of a...
September 2010
637 pages
Bladder Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Bladder Cancer Therapy Area Pipeline Report contains detailed information on the bladder cancer drug pipeline. This report provides insight into the pipeline status of bladder...
September 2010
141 pages
Breast Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Breast Cancer Therapy Area Pipeline Report contains detailed information on the breast cancer drug pipeline. This report provides insight into the pipeline status of breast ca...
September 2010
1178 pages
Cervical Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Cervical Cancer Therapy Area Pipeline Report contains detailed information on the cervical cancer drug pipeline. This report provides insight into the pipeline status of cervi...
September 2010
120 pages
Colorectal and Colon Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Colorectal and Colon Cancer Therapy Area Pipeline Report contains detailed information on the colorectal and colon cancer drug pipeline. This report provides insight into the...
September 2010
957 pages
Congestive Heart Failure Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Congestive Heart Failure Therapy Area Pipeline Report contains detailed information on the congestive heart failure drug pipeline. This report provides insight into the pipeli...
September 2010
455 pages
Head and Neck Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Head and Neck Cancer Therapy Area Pipeline Report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline statu...
September 2010
423 pages
Hepatitis B Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Hepatitis B Therapy Area Pipeline Report contains detailed information on the hepatitis b drug pipeline. This report provides insight into the pipeline status of hepatitis b d...
September 2010
344 pages
Hepatitis C Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Hepatitis C Therapy Area Pipeline Report contains detailed information on the hepatitis c drug pipeline. This report provides insight into the pipeline status of hepatitis c d...
September 2010
881 pages
Hepatitis Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Hepatitis Therapy Area Pipeline Report contains detailed information on the hepatitis drug pipeline. This report provides insight into the pipeline status of hepatitis drugs b...
September 2010
68 pages
Kidney Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Kidney Cancer Therapy Area Pipeline Report contains detailed information on the kidney cancer drug pipeline. This report provides insight into the pipeline status of kidney ca...
September 2010
431 pages
Liver Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Liver Cancer Therapy Area Pipeline Report contains detailed information on the liver cancer drug pipeline. This report provides insight into the pipeline status of liver cance...
September 2010
419 pages
Ovarian Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Ovarian Cancer Therapy Area Pipeline Report contains detailed information on the ovarian cancer drug pipeline. This report provides insight into the pipeline status of ovarian...
September 2010
589 pages
Pancreatic Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Pancreatic Cancer Therapy Area Pipeline Report contains detailed information on the pancreatic cancer drug pipeline. This report provides insight into the pipeline status of p...
September 2010
403 pages
Prostate Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Prostate Cancer Therapy Area Pipeline Report contains detailed information on the prostate cancer drug pipeline. This report provides insight into the pipeline status of prost...
September 2010
847 pages
Skin Cancer and Melanoma Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Skin Cancer and Melanoma Therapy Area Pipeline Report contains detailed information on the skin cancer and melanoma drug pipeline. This report provides insight into the pipeli...
September 2010
550 pages
Type I Diabetes Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Type I Diabetes Therapy Area Pipeline Report contains detailed information on the type i diabetes drug pipeline. This report provides insight into the pipeline status of type...
September 2010
230 pages
Type II Diabetes Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Type II Diabetes Therapy Area Pipeline Report contains detailed information on the type ii diabetes drug pipeline. This report provides insight into the pipeline status of typ...
September 2010
1685 pages
China Diabetes Market Report & Outlook For 2010-2015
US$ 800.00
As the second largest economy of the world, China enjoys pink of health but its affluence is giving rise to another sickness- a rapid increase in a life-style disease called diabetes. With the Chinese...
September 2010
89 pages
Indian Diabetes Market Report & Outlook For 2010-2015
US$ 800.00
With around 51 Million diabetes patients, India promises to be amongst the most lucrative diabetes markets in the world. In 2009, the total sales of Insulin and Non-Insulin Anti-diabetics reached US$...
September 2010
89 pages
Incontinence - Philippines
US$ 990.00
... -conscious users favoured these more affordable brands. Euromonitor International's Incontinence in Philippines report offers a comprehensive guide to the size and shape of the ... Care Wipes and Floor Cleaning Systems, Light Incontinence, Luxury Toilet Paper, Moderate/Heavy Incontinence, Napkins, Nappies/Diapers, Personal Wipes, Pocket ...
July 2010
25 pages
The 2011 Clinical Chemistry And Immunodiagnostics Markets: US, Europe, Japan
US$ 23,520.00
The 2011 Clinical Chemistry And Immunodiagnostics Markets: US, Europe, Japan - Product Development Opportunities And Business Expansion Strategies For Instrument And Reagent Suppliers During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The ...
June 2010
1115 pages
